Peripheral blood abnormalities in Alzheimer disease: Evidence for early endothelial dysfunction

Alzheimer Disease and Associated Disorders

Volumn 16, Issue 3, 2002, Pages 150-155

  Borroni, B ^a   Volpi, R ^a   Martini, G ^a   Del Bono, R ^a   Archetti, S ^a   Colciaghi, F ^a   Maalikjy Akkawi, N ^a   Di Luca, M ^a   Romanelli, G ^a   Caimi, L ^a   Padovani, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Alzheimer disease; Endothelial dysfunction; Hemostasis changes

Indexed keywords

BETA THROMBOGLOBULIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; PROTHROMBIN; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENDOTHELIUM INJURY; FEMALE; FIBRINOLYSIS; HUMAN; LABORATORY DIAGNOSIS; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTEMIC DISEASE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BLOOD COAGULATION FACTORS; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; THROMBOMODULIN;

EID: 18544375622     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200207000-00004     Document Type: Article

References (42)

1. The amyloid precursor protein of Alzheimer's disease is released by human platelets
2. Evidence that tumor necrosis factor alfa-converting enzyme is involved in regulated alfa-secretase cleavage of Alzheimer amyloid precursor protein
3. Platelets are the primary source of amyloid β-peptide in human blood
4. Characterization and differential distribution of the three major human protein kinase C isoenzymes of the central nervous system in normal and in Alzheimer's disease brains
5. The underlying molecular mechanism of apolipoprotein E polymorphism: Relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease
6. Moderate and advanced Alzheimer's patients exhibit platelet activation differences
7. Can disturbed brain microcirculation cause Alzheimer's disease?
8. Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome
9. Differential pattern of platelet APP isoforms: An early marker for Alzheimer Disease
10. Glutamate uptake is decreased in platelets from Alzheimer's disease patients
11. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex and education
12. Intact Alzheimer amyloid precursor protein (APP) is present in platelets membrane and is encoded by platelet mRNA
13. Alzheimer's disease: Initial report of the purification and characterization of novel cerebrovascular amyloid protein
14. The importance of coexistent disease in the occurrence of postoperative complications and one year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement
15. Cerebrovascular pathology in Alzheimer's disease: Cause, effect or epiphenomenon?
16. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
17. Identification of a novel aspartic protease (Asp2) as β-secreatase
18. Platelet of Alzheimer patients: Increased counts and subnormal uptake and accumulation of [14C]5-hydroxytryptamine
19. β-amyloid vasoactivity in Alzheimer's disease
20. Dementia after ischemic stroke: A population-based study in Rochester, Minnesota (1960-1984)
21. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by disintegrine metalloprotease
22. The risk of dementia among persons with diabetes mellitus: A population-based cohort study
23. Proteolitic processing of Alzheimer's disease βA4 amyloid precursor protein in human platelets
24. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease
25. Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease
26. Amyloid protein precursor stimulates excitatory amino acid transport
27. Platelet protein kinase C levels in Alzheimer's disease
28. Reduction of platelet phospholipase C activity in patients with Alzheimer disease
29. Reduction of platelet PLC-delta 1 activity in AD associated with a specific apolipoprotein genotype (epsilon 3/epsilon 3)
30. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
31. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin II
32. Altered amyloid protein processing in platelets of patients with Alzheimer disease
33. Platelet activation in Alzheimer disease
34. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein
35. Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease?
36. Beta amyloid mediated vasoactivity and vascular endothelial damage
37. In vivo vascular damage, leukocyte activation and inflammatory response induced by β-amyloid
38. Epidemiology of the dementias: Recent developments and new approaches
39. Protease nexin II (amyloid β-protein precursor): A platelet α-granule protein
40. B-secretase cleavage of Alzheimer's amyloid precursor protein by transmembrane aspartic protease BACE
41. Progression of regional neuropathology in Alzheimer disease and normal elderly: Findings from the Nun study
42. Prospective study of increased platelet membrane fluidity as a risk factor for AD: Results at 5 years